or their salts where R1 and R2 mean independently hydrogen, halogen atom, trifluoromethyl-group, C1-C6-alkyl or C1-C6-alkoxy-group; Y means groups or =CH where underlined atom takes part in cyclic system; X means groups -O-, -S-, -CR7R8-, -CH2-CH2-, -CH= CH--CH2-, -CH2-CH= CH-, -CH2CH2CH2-, -CH= CH-, -NR9-(C=O)-, -O-CH2-, -(C=O)- or -(S=O)- where R7, R8, R9 mean independently hydrogen atom or C1-C6-alkyl; r = 1, 2 or 3; M = 1 or 2; n = 1 when m = 1 and n = 0 when m = 2; R4 and R5 each means hydrogen atom or when m = 2 then both in common can form a bond; R6 is hydroxyl or C1-C8-alkoxy-group, or its pharmaceutically acceptable salt under condition that compounds 10-[3-(3-carbomethoxy-1-piperidyl)-propyl} -phenothiazine and 10-[3-(3-carbohexoxy-1-piperidyl)-propyl] -phenothiazine are not included. Compounds of the formula (I) inhibit neurogenic inflammation and can be used in medicine. Invention describes also method of synthesis of compounds of the formula (I), pharmaceutical composition and method of inhibition of neurogenic inflammation. EFFECT: improved method of synthesis, valuable medicinal properties. 9 cl, 2 tbl, 18 ex"/> N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF NEUROGENIC INFLAMMATION
首页> 外国专利> N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF NEUROGENIC INFLAMMATION

N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF INHIBITION OF NEUROGENIC INFLAMMATION

机译:N-取代的氮杂杂环羧酸或其药学上可接受的盐,其合成方法,基于其的药物组合物和抑制神经原性发炎的方法

摘要

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to novel N-substituted azaheterocyclic carboxylic acid of the formula (I) or their salts where R1 and R2 mean independently hydrogen, halogen atom, trifluoromethyl-group, C1-C6-alkyl or C1-C6-alkoxy-group; Y means groups or =CH where underlined atom takes part in cyclic system; X means groups -O-, -S-, -CR7R8-, -CH2-CH2-, -CH= CH--CH2-, -CH2-CH= CH-, -CH2CH2CH2-, -CH= CH-, -NR9-(C=O)-, -O-CH2-, -(C=O)- or -(S=O)- where R7, R8, R9 mean independently hydrogen atom or C1-C6-alkyl; r = 1, 2 or 3; M = 1 or 2; n = 1 when m = 1 and n = 0 when m = 2; R4 and R5 each means hydrogen atom or when m = 2 then both in common can form a bond; R6 is hydroxyl or C1-C8-alkoxy-group, or its pharmaceutically acceptable salt under condition that compounds 10-[3-(3-carbomethoxy-1-piperidyl)-propyl} -phenothiazine and 10-[3-(3-carbohexoxy-1-piperidyl)-propyl] -phenothiazine are not included. Compounds of the formula (I) inhibit neurogenic inflammation and can be used in medicine. Invention describes also method of synthesis of compounds of the formula (I), pharmaceutical composition and method of inhibition of neurogenic inflammation. EFFECT: improved method of synthesis, valuable medicinal properties. 9 cl, 2 tbl, 18 ex
机译:领域:有机化学,药学。物质:本发明涉及式(I)的新型N-取代的氮杂杂环羧酸。<图像文件=“ 00000005.GIF” he =“ 41” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 55” />或它们的盐,其中R 1 和R 2 分别表示氢,卤素原子,三氟甲基,C 1 -C 6 -烷基或C 1 -C 6 -烷氧基; Y表示组 = CH其中带下划线的原子参与循环系统; X表示组-O-,-S-,-CR 7 R 8 -,-CH 2 -CH 2 -,-CH = CH--CH 2 -,-CH 2 -CH = CH-,-CH 2 CH 2 CH 2 -,-CH = CH-,-NR 9 -(C = O)-,-O-CH 2 < / Sub>-,-(C = O)-或-(S = O)-,其中R 7 ,R 8 ,R 9 独立地是指氢原子或C 1 -C 6 -烷基; r = 1、2或3; M = 1或2;当m = 1时n = 1,当m = 2时n = 0; R 4 和R 5 分别表示氢原子,或者当m = 2时,两者可以形成一个键。在化合物10- [3-]的条件下,R 6 是羟基或C 1 -C 8 -烷氧基或其药学上可接受的盐。不包括(3-羰基甲氧基-1-哌啶基)-丙基}-吩噻嗪和10- [3-(3-羰基己氧基-1-哌啶基)-丙基]-吩噻嗪。式(I)的化合物抑制神经源性炎症并且可以用于医学中。本发明还描述了式(I)化合物的合成方法,药物组合物和抑制神经源性炎症的方法。功效:改良的合成方法,有价值的药用特性。 9厘升,2汤匙,18前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号